Literature DB >> 8078810

A new case of malignant mesothelioma of the tunica vaginalis testis. Immunohistochemistry in comparison with an adenomatoid tumor of the testis.

H Moch1, H Ohnacker, R Epper, F Gudat, M J Mihatsch.   

Abstract

Malignant mesothelioma of the tunica vaginalis testis is an extremely rare tumor with 41 previously reported cases. The histological and immunohistological features of a new case in an 80-year-old patient are described and compared with an adenomatoid tumor of the tunica vaginalis testis, which is considered to be the benign variant of malignant mesothelioma. Both tumors revealed strong cytoplasmic staining for a panepithelial antibody (Lu-5) and membranous staining for BMA-120 (a mesothelial/endothelial cell marker) but yielded negative staining results with the endothelial cell markers QBend-10 (CD 34), Factor VIII-related antigen (vWF) and UEA-1. There was also negative staining for CEA, Ber-EP4, HEA-125 and Blood group related antigens A, B, H. An identical staining pattern was evident in normal and reactive mesothelial cells. Our data support a mesothelial rather than an endothelial derivation of the adenomatoid tumor studied.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078810     DOI: 10.1016/S0344-0338(11)80414-0

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

1.  Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Luigi De Maria; Antonio Caputi; Giovanni Maria Ferri; Gabriella Serio
Journal:  Environ Health       Date:  2019-08-30       Impact factor: 5.984

2.  Malignant mesothelioma of the tunica vaginalis of the testis without exposure to asbestos.

Authors:  Ashish Goel; Akansha Agrawal; Rajiv Gupta; Smriti Hari; A B Dey
Journal:  Cases J       Date:  2008-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.